1. Home
  2. XPEL vs STAA Comparison

XPEL vs STAA Comparison

Compare XPEL & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XPEL Inc.

XPEL

XPEL Inc.

HOLD

Current Price

$38.40

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$17.48

Market Cap

867.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPEL
STAA
Founded
1999
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
867.9M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
XPEL
STAA
Price
$38.40
$17.48
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$22.19
AVG Volume (30 Days)
255.6K
1.2M
Earning Date
05-05-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
12.12
N/A
EPS
1.85
N/A
Revenue
$476,200,000.00
$239,442,000.00
Revenue This Year
$12.64
$33.83
Revenue Next Year
$11.98
$8.16
P/E Ratio
$20.51
N/A
Revenue Growth
13.27
N/A
52 Week Low
$24.27
$14.69
52 Week High
$55.91
$30.81

Technical Indicators

Market Signals
Indicator
XPEL
STAA
Relative Strength Index (RSI) 28.17 42.85
Support Level $35.10 $17.13
Resistance Level $38.79 $18.19
Average True Range (ATR) 1.49 0.96
MACD -0.13 -0.01
Stochastic Oscillator 19.39 15.15

Price Performance

Historical Comparison
XPEL
STAA

About XPEL XPEL Inc.

XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: